Overview Practicability and Acceptability of Stylomax® in Children Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary Primary objective: to evaluate the practicability and acceptability of STYLOMAX®, a new injection device for MAXOMAT®, in children, for 1 year. Phase: Phase 3 Details Lead Sponsor: Sanofi